Oral Answers to Questions

Debate between Jane Ellison and Michael Fabricant

Tuesday 5th January 2016 Commons Chamber

[Jane Ellison]

I thank the hon. Gentleman for his words, as does my hon. Friend the Under-Secretary of State for Life Sciences. With regard to the matter that he just mentioned, I know that it is something that NHS England is reviewing and it will come forward with a view in due course.

[Michael Fabricant (Lichfield) (Con)]

Will my hon. Friend join me in praising the work of the Institute of Translational Medicine at the University of Birmingham Medical School? It is doing outstanding, world-wide standard work in developing cures and treatments for such rare diseases, and indeed for more common diseases such as cancer.

[Jane Ellison]

I absolutely join my hon. Friend in that and agree with his very well-deserved words of congratulation. I know that the Under-Secretary of State for Life Sciences has visited the institute and is—as everyone is—hugely impressed with it. I also join my hon. Friend the Member for Lichfield (Michael Fabricant) and others in congratulating Charlie Craddock on his CBE in the new year honours list.

Oral Answers to Questions

Debate between Jane Ellison and Michael Fabricant

Thursday 26th November 2015 Commons Chamber

[Michael Fabricant (Lichfield) (Con)]

4. What discussions she has had with the Secretary of State for Health on the Freedom to Donate campaign; and if she will make a statement.

[The Parliamentary Under-Secretary of State for Health (Jane Ellison)]

Making sure that the blood supply is safe is an absolute priority. Donor deferral for men who have sex with men was changed from lifetime to 12 months in 2011, but four years later it is time to look again at the question. Public Health England has just undertaken an anonymous survey of donors, and I am pleased to say that SaBTO—the Advisory Committee on the Safety of Blood, Tissues and Organs—will review the issue in 2016.

[Michael Fabricant]

The safety of blood is of course paramount, but the Minister will know that when I met her in December 2014 to discuss the issue, there were two matters about which I was very disturbed. One was someone from the Advisory Committee on the Safety of Blood, Tissues and Organs saying that the word of gay people was somehow less valuable than the word of straight people—that was disgraceful. Secondly, the Minister promised me that survey work would be available at the time of the general election, but when I put down a written question about it, she said that, in fact, such survey work was not being done—although she now says it is. I felt that she misled me at the time. Can she say more about how we are finally going to achieve equality in this matter? Many clinicians feel it is long overdue.

[Jane Ellison]

My hon. Friend and I did have a meeting, and I can confirm that the Public Health England survey has been undertaken and is currently being analysed. I do not recall that an official made that point. It is important to put it on the record that the blood service does not discriminate on sexual orientation: lesbians are free to give blood and their blood donations are much appreciated. The deferral period is based on sexual activity and it applies to a number of groups other than men who have sex with men. As I say, SaBTO will review the issue in the light of the PHE survey. I am always happy to discuss this with my hon. Friend.

Oral Answers to Questions

Debate between Jane Ellison and Michael Fabricant

Tuesday 13th January 2015 Commons Chamber

[Michael Fabricant (Lichfield) (Con)]

The Institute of Translational Medicine at Birmingham university medical school is probably the top place in Europe for genetic research into innovative cancer cures. I have visited it. Will the Secretary of State visit it, and will he ensure that funding continues for that department?

[The Parliamentary Under-Secretary of State for Health (Jane Ellison)]

My hon. Friend is right to champion that project. The Prime Minister’s 100,000 genomes project is leading the world and has the potential to transform the future of health care. The Institute of Translational Medicine in Birmingham will accelerate access to new diagnostics, new drugs and medical devices and provide a focus for life sciences. My hon. Friend will be pleased to know that my colleague with responsibility for life sciences, my hon. Friend the Member for Mid Norfolk (George Freeman), plans to visit on 3 March.